Table 3.13 The dose of Noradrenalin between the two group (µg / kg / min) used in treatment Time Total (n=45) Group 1 (n=26) Group 2 (n=19) P (1 - 2) T0 0.68 ± 0.89 0.7 ± 0.81 0.66 ± 0.71 >0.05 T1 0.55 ± 0.31 0.53 ± 0.33 0.60 ± 0.41 >0.05 T3 0.50 ± 0.26 0.48 ± 0.21 0.52 ± 0.36 >0.05 T6 0.16 ± 0.20 0.11 ± 0.22 0.19± 0.25 >0.05 T24 0.15± 0.22 0.10 ± 0.21 * 0.19 ± 0.27 <0.05 T48 0.02 ± 0.03 * 0.01 ± 0.04 * 0.03 ± 0.04 * <0.05 T72 0.02 ± 0.03 * 0.01 ± 0.05 * 0.04 ± 0.07 * <0.05 D4 0.03 ± 0.05 * 0.01 ± 0.06 * 0.05 ± 0.06 * <0.05 D5 0.02 ± 0.03 * 0.01 ± 0.01 * 0.03 ± 0.04 * <0.05 D6 0.01 ± 0.02 * 0.007 ± 0.01 * 0.02 ± 0.02 * <0.05 D7 0.01 ± 0.02 * 0.008 ± 0.02 * 0.02 ± 0.01 * <0.05 Comment: The Noradrenalin dose decreases after IABP, significantly changed affter 48 hours: 0.026 ± 0.03 µg / kg / min (p <0.05).